Dr. Christopher Starr, MD

NPI: 1720076185
Total Payments
$279,545
2024 Payments
$35,357
Companies
29
Transactions
315
Medicare Patients
9,746
Medicare Billing
$937,890

Payment Breakdown by Category

Consulting$201,734 (72.2%)
Other$58,630 (21.0%)
Food & Beverage$13,381 (4.8%)
Travel$5,800 (2.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $201,734 91 72.2%
Honoraria $30,650 23 11.0%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $16,080 4 5.8%
Food and Beverage $13,381 160 4.8%
Compensation for serving as faculty or as a speaker for a medical education program $9,400 3 3.4%
Travel and Lodging $5,800 33 2.1%
Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $2,500 1 0.9%

Top Paying Companies

Company Total Records Latest Year
Allergan, Inc. $45,908 75 $0 (2022)
Novartis Pharmaceuticals Corporation $41,064 25 $0 (2022)
Johnson & Johnson Surgical Vision, Inc. $36,910 18 $0 (2021)
Kala Pharmaceuticals, Inc. $32,312 15 $0 (2022)
Bausch & Lomb Americas Inc. $32,203 24 $0 (2024)
Dompe US, Inc. $22,764 30 $0 (2024)
Shire North American Group Inc $18,547 28 $0 (2018)
SUN PHARMACEUTICAL INDUSTRIES INC. $10,125 17 $0 (2024)
TearLab Corp $9,510 11 $0 (2024)
ABBVIE INC. $6,825 7 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $35,357 31 Bausch & Lomb Americas Inc. ($18,614)
2023 $9,862 14 Bausch & Lomb Americas Inc. ($5,369)
2022 $16,636 21 Bausch & Lomb Americas Inc. ($8,220)
2021 $31,744 54 Allergan, Inc. ($18,211)
2020 $110,536 62 Novartis Pharmaceuticals Corporation ($29,488)
2019 $34,227 63 Dompe US, Inc. ($7,767)
2018 $20,277 42 Shire North American Group Inc ($10,741)
2017 $20,907 28 Allergan Inc. ($9,045)

All Payment Transactions

315 individual payment records from CMS Open Payments — Page 1 of 13

Date Company Product Nature Form Amount Type
11/15/2024 Bausch & Lomb Americas Inc. XIIDRA (Drug), MIEBO Food and Beverage In-kind items and services $83.00 General
Category: Ophthalmology
11/11/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $2,900.00 General
11/09/2024 SUN PHARMACEUTICAL INDUSTRIES INC. Cequa (Drug) Food and Beverage In-kind items and services $30.75 General
Category: Ophthalmology
11/04/2024 Bausch & Lomb Americas Inc. XIIDRA (Drug) Consulting Fee Cash or cash equivalent $1,700.00 General
Category: Ophthalmology
11/01/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $1,075.00 General
10/31/2024 Bausch & Lomb Americas Inc. XIIDRA (Drug), MIEBO Food and Beverage In-kind items and services $143.53 General
Category: Ophthalmology
10/31/2024 Bausch & Lomb Americas Inc. XIIDRA (Drug), MIEBO Travel and Lodging In-kind items and services $56.11 General
Category: Ophthalmology
10/25/2024 Bausch & Lomb Americas Inc. XIIDRA (Drug) Consulting Fee Cash or cash equivalent $2,550.00 General
Category: Ophthalmology
10/24/2024 Alcon Vision LLC Consulting Fee Cash or cash equivalent $2,000.00 General
10/19/2024 Sight Sciences, Inc. TEARCARE SYSTEM (Device) Food and Beverage In-kind items and services $70.04 General
Category: Ophthalmology
10/19/2024 ABBVIE INC. Food and Beverage In-kind items and services $41.66 General
10/18/2024 Bausch & Lomb Americas Inc. Consulting Fee Cash or cash equivalent $1,700.00 General
10/18/2024 Bausch & Lomb Americas Inc. XIIDRA (Drug) Food and Beverage In-kind items and services $89.97 General
Category: Ophthalmology
10/18/2024 Bausch & Lomb Americas Inc. Food and Beverage In-kind items and services $63.04 General
10/18/2024 Alcon Vision LLC Food and Beverage In-kind items and services $41.19 General
10/18/2024 Dompe US, Inc. OXERVATE (Drug) Food and Beverage In-kind items and services $28.61 General
Category: SOLUTION/ DROPS
08/22/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $700.00 General
08/19/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $700.00 General
07/26/2024 Bausch & Lomb Americas Inc. Consulting Fee Cash or cash equivalent $8,075.00 General
07/23/2024 Ocular Therapeutix, Inc. DEXTENZA (Drug) Food and Beverage In-kind items and services $15.87 General
Category: Corticosteroid intracanalicular insert
06/10/2024 Bausch & Lomb Americas Inc. XIIDRA (Drug) Consulting Fee Cash or cash equivalent $1,062.50 General
Category: Ophthalmology
05/31/2024 Bausch & Lomb Americas Inc. XIIDRA (Drug) Consulting Fee Cash or cash equivalent $850.00 General
Category: Ophthalmology
05/09/2024 TearLab Corp ScoutPro Osmolarity System (Device) Consulting Fee Cash or cash equivalent $1,750.00 General
Category: Ophthalmology
05/01/2024 Bausch & Lomb Americas Inc. XIIDRA (Drug) Consulting Fee Cash or cash equivalent $1,275.00 General
Category: Ophthalmology
04/19/2024 Alcon Research LLC Consulting Fee Cash or cash equivalent $4,000.00 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 18 2,571 3,354 $1.2M $218,822
2022 24 2,750 3,435 $1.8M $266,379
2021 21 2,676 3,323 $1.9M $276,128
2020 21 1,749 2,247 $1.4M $176,561
Total Patients
9,746
Total Services
12,359
Medicare Billing
$937,890
Procedure Codes
84

All Medicare Procedures & Services

84 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 583 684 $270,180 $72,382 26.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 197 197 $107,759 $26,890 25.0%
68761 Closure of tear duct opening using plug Office 2023 107 238 $186,000 $25,588 13.8%
92014 Established patient complete exam of visual system Office 2023 131 135 $55,430 $13,988 25.2%
83861 Microfluid analysis of tears Office 2023 283 593 $48,626 $12,937 26.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 114 164 $46,740 $12,848 27.5%
66821 Removal of recurring cataract in lens capsule using a laser Office 2023 35 38 $137,256 $11,442 8.3%
92004 New patient complete exam of visual system Office 2023 92 92 $45,080 $10,460 23.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 69 70 $38,850 $9,577 24.7%
92202 Extended exam of the back part of the eye with optic nerve drawing Office 2023 623 651 $113,925 $8,320 7.3%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 18 18 $12,600 $3,304 26.2%
68801 Dilation of tear drainage opening Office 2023 20 46 $29,900 $2,985 10.0%
83516 Analysis of substance using immunoassay technique, multiple step method Office 2023 109 227 $53,572 $2,543 4.7%
92133 Imaging of optic nerve Office 2023 76 78 $12,480 $2,297 18.4%
92025 Ct scan of cornea Office 2023 40 41 $7,216 $1,329 18.4%
92083 Exam of visual field with extended testing Office 2023 16 16 $4,944 $878.40 17.8%
67820 Removal of eyelashes using forceps Office 2023 46 54 $22,626 $784.61 3.5%
65205 Removal of foreign body from external eye (conjunctiva) Office 2023 12 12 $4,824 $267.60 5.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 700 833 $321,976 $86,383 26.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 231 231 $126,357 $30,728 24.3%
68761 Closure of tear duct opening using plug Office 2022 106 263 $203,825 $28,261 13.9%
66982 Complex removal of cataract with insertion of prosthetic lens Facility 2022 23 32 $277,856 $21,060 7.6%
66984 Removal of cataract with insertion of prosthetic lens Facility 2022 28 39 $281,736 $19,591 7.0%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 72 72 $50,400 $12,681 25.2%
92202 Extended exam of the back part of the eye with optic nerve drawing Office 2022 739 775 $135,625 $9,970 7.4%

About Dr. Christopher Starr, MD

Dr. Christopher Starr, MD is a Ophthalmology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1720076185.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Starr, MD has received a total of $279,545 in payments from pharmaceutical and medical device companies, with $35,357 received in 2024. These payments were reported across 315 transactions from 29 companies. The most common payment nature is "Consulting Fee" ($201,734).

As a Medicare-enrolled provider, Starr has provided services to 9,746 Medicare beneficiaries, totaling 12,359 services with total Medicare billing of $937,890. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.

Practice Information

  • Specialty Ophthalmology
  • Other Specialties Cornea and External Diseases Specialist
  • Location New York, NY
  • Active Since 10/10/2005
  • Last Updated 10/11/2023
  • Taxonomy Code 207W00000X
  • Entity Type Individual
  • NPI Number 1720076185

Products in Payments

  • XIIDRA (Drug) $58,698
  • Oxervate (Drug) $17,915
  • EYSUVIS (Drug) $16,917
  • INVELTYS (Drug) $12,250
  • CEQUA (cyclosporine ophthalmic solution) 0.09% (Drug) $7,644
  • RESTASIS (Drug) $7,438
  • TearLab Osmolarity System (Device) $5,458
  • Flarex (Drug) $2,992
  • VUITY (Drug) $2,839
  • MIEBO (Drug) $2,242
  • LIPIFLOW SYSTEM ACTIVATOR (DISPOSABLE) (Device) $2,188
  • TEARLAB OSMOLARITY SYSTEM (Device) $2,100
  • TEPEZZA (Biological) $2,063
  • ScoutPro Osmolarity System (Device) $1,952
  • CEQUA (Drug) $1,800
  • Eye Health (Device) $1,704
  • InflammaDry (Device) $1,537
  • TYRVAYA (Drug) $1,453
  • CE-marked KXLA system (Device) $1,125
  • TearCare (Device) $750.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Ophthalmology Doctors in New York